Arrowhead Research reported 39.19 in PE Price to Earnings for its fiscal quarter ending in June of 2026.





Pe Change Date
Agios Pharmaceuticals 3.56 0 Mar/2026
Alnylam Pharmaceuticals 75.64 4.4 Jun/2026
Anika Therapeutics 47.54 27.2 Jun/2024
Arrowhead Research 39.19 0 Jun/2026
Incyte 14.45 0.9 Jun/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Ligand Pharmaceuticals 84.31 27.81 Jun/2026
Merck 32.26 15.74 Jun/2026
Moderna 27.22 14.51 Jun/2023
Novartis 22.41 2.24 Jun/2026
Sarepta Therapeutics 27.27 0 Mar/2026
TG Therapeutics 19.64 7.65 Jun/2026
Vertex Pharmaceuticals 28.05 2.22 Jun/2026
Xencor 29.92 3.22 Sep/2022